Cell technology spinout Impulsonics closes £450k funding

Impulsonics founders at NEC competition

Impulsonics has closed its first funding round to advance the development of its unique biotech automation platform and begin customer trials. Impulsonics is an award-winning cell technology spinout from the University of Bristol’s Ultrasonics and Non-Destructive Testing Research Group, building on over a decade of deep research and leveraging world-leading expertise in acoustics. The company…

Read More

Medtech startup Neuronostics raises over £2 million

Neuronostics team - nine men and women smiling, wearing business casual

Multi-award-winning medtech startup, Neuronostics, has raised more than £2m in funding to develop its pioneering epilepsy diagnosis technology. The company received £2.1m in an oversubscribed seed funding round led by the Ascension Life Fund. Chris Wheatcroft, Investment Director at the Ascension Life Fund said: “We are delighted to have invested in Neuronostics, whose software as…

Read More

Biotech startup Impulsonics awarded £300,000 Innovate UK grant

Impulsonics founders at NEC competition

Bristol-based startup, Impulsonics has been awarded the prestigious ICURe spinout support grant of £300,000 to enable the development of its unique technology platform for biotech automation. The grant will enable the company to develop its flexible acoustic platform for key applications in the process of growing cells in order to streamline cell culture automation. This…

Read More

Siloton co-founders awarded Institute of Physics’ Clifford Paterson Medal

Siloton founders, 2 men wearing blue shirts in front of trees

Dr Alasdair Price and Dr Euan Allen, Co-founders of healthtech startup Siloton, have been awarded the Institute of Physics’ Clifford Paterson Medal for ‘exceptional early-career contributions to the application of physics in an industrial or commercial context’.  Siloton joined SETsquared Bristol’s incubation programme in January 2023 to further develop its innovative diagnostic imaging technology to…

Read More

Moropo releases innovative app testing tool

Moropo founders with demo

Bristol tech company Moropo has launched a new mobile app testing tool for software agencies and startups. The web-based automation platform comprises a low-code test creator, a test scheduling system and a results inspector, and works for both iOS and Android. Moropo joined SETsquared Bristol in March 2022 and has since secured over £340,000 in…

Read More

Siloton: Photonics technology to prevent sight loss

Following our member company Siloton’s £470k raise, which will further fund its diagnostic imaging technology to prevent sight loss, we had a chat with Co-founder and CEO, Alasdair Price, to hear his story… Siloton key facts Start date: 1 April 2020 Market sector: Healthtech Location: Bristol Company growth status: Seed Stage In your own words, what does Siloton do? Siloton…

Read More

Rosa Biotech secures £415,000 to accelerate early disease screening

Three Rosa Biotech scientists in lab looking at samples

Bio-sensing pioneer Rosa Biotech has secured £415,000 from angel investors and announced plans to accelerate development of its bio-sensing technology, designed to enable cost effective, early-stage screening of a range of life-threatening diseases. The University of Bristol healthtech spinout joined SETsquared Bristol in February 2023. It is initially targeting the early identification of non-alcoholic fatty…

Read More

Milbotix: Transforming dementia care with SmartSocks™

Zeke Steer, Founder of Milbotix with Smart Sensor Sock. Photo credit to St Monica Trust

Following our company Milbotix’s recent investment from Alzheimer’s Society and £1.15m in non-dilutive funding awards, we had a chat with CEO, Dr Zeke Steer, to hear his story… Milbotix key facts Start date: 24 February 2020 Market sector: Healthtech/wearables/IoT Location: Bristol and Oxford Number of employees: 8 Company growth status: Startup Milbotix is partnered with the UK Dementia Research Institute and University…

Read More